Arbutus Biopharma (ABUS) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$181.7M

Revenue (quarter)

$1.0M

Revenue growth (year over year)

−90.56%

Gross profit (trailing twelve months)

$181.7M

Gross margin

100.00%

Net income (trailing twelve months)

$153.1M

Net income (quarter)

−$5.1M

Net income growth (year over year)

−303.84%

Net margin

84.23%

Return on equity

89.58%

EPS (trailing twelve months)

$0.79

Book value per share

$1.31

P/E (trailing twelve months)

5.42

Price to book

3.20

Debt to assets

5.58%

Payout ratio

—

Dividend yield

—

Company profile

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

• Is Arbutus Biopharma (ABUS) profitable?

  Yes. Arbutus Biopharma earned $153.1M in net income over the trailing twelve months, a net margin of 84.23%.

• How much revenue does Arbutus Biopharma (ABUS) make?

  Arbutus Biopharma generated $181.7M in revenue over the trailing twelve months, down 90.56% year over year.

• What is ABUS's P/E ratio?

  Arbutus Biopharma trades at 5.4 times trailing twelve-month earnings, on an EPS of $0.79.

• How do I buy stock in Arbutus Biopharma (ABUS)?

  ABUS trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.